CAMK2G and breast carcinoma: Taken together, these data demonstrate that both CaMKII expression and phosphorylation at T286 are increased in breast cancer tissue, as well as lymph node metastases, and may be potentially useful biomarkers to predict patient outcome and likelihood of metastasis.